ComInnex

Budapest, Hungary Founded: 2006 • Age: 20 yrs Acquired By X-Chem
Custom chemical synthesis and business development services are provided.
Annual revenue - Latest available
Total funding - 2 rounds
Employees - Tracked headcount
Investors 2 Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About ComInnex

ComInnex is a company based in Budapest (Hungary) founded in 2006 was acquired by X-Chem in October 2021. ComInnex offers products and services including DNA-Encoded Libraries (DEL) and ArtemisAI Platform.

  • Headquarter Budapest, Hungary
  • Sectors
    Chemicals & Materials
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name X-Chem, Inc.
Operational Areas
Chemicals & Materials → Industrial & Technical Services Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    $281.72 K (USD), Grant

    Jan 01, 2021

  • Investors
    X-Chem

    & 1 more

  • Employee Count
    Not available
  • Acquired by
    X-Chem

    (Oct 25, 2021)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of ComInnex

ComInnex offers a comprehensive portfolio of products and services, including DNA-Encoded Libraries (DEL) and ArtemisAI Platform.

Product name locked
Category locked
Primary

DEL technology is utilized for screening and identifying small molecule candidates in various therapeutic areas.

Product name locked
Category locked
Locked

The ArtemisAI platform is employed to analyze data and generate insights for accelerating drug discovery processes.

Funding Insights of ComInnex

Investors in ComInnex

ComInnex has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include X-Chem and European Union.

All
Institutional
Investor Description Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Locked Locked Locked
Small molecule drug discovery platform is provided to researchers.
Locked Locked Locked
Premium access

Investor details for ComInnex

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by ComInnex

Investments
Premium access

Investment portfolio details for ComInnex

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - ComInnex

Premium access

Detailed financials for ComInnex

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Cominnex Comparisons

ComInnex Primary company
Description
Custom chemical synthesis and business development services ...
Location
Budapest, Hungary
Founded Year
2006
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for ComInnex

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of ComInnex

Premium access

Detailed competitors of ComInnex

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Cominnex

Premium access

Complete news archive for ComInnex

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about ComInnex

ComInnex was founded in 2006 and raised its 1st funding round 14 years after it was founded.

ComInnex is headquartered in Budapest, Hungary.

Alexander Drijver is the current CEO of ComInnex.

ComInnex was founded in 2006 and is based in Budapest, Hungary. Operations focus on the chemical sector, where custom synthesis services are offered alongside business development support. Additional services are provided to clients in related fields. The company is led by CEO Alexander Drijver, with activities centered in Europe. Expertise in chemical processes is utilized to meet specific project needs.

ComInnex offers DNA-Encoded Libraries (DEL) and ArtemisAI Platform.

ComInnex has 2 investors. Key investors include X-Chem, and European Union.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available